this week

List

June 1st, 2011

Diflucan Cost

[This review was originally posted at the Nieman Journalism Lab Diflucan Cost, on May 13, 2011.]

Leaving the old ad model behind: Much of the commentary about digital news this week was generated by two big reports, one on the business of digital journalism and the other on its consumption. We'll start on the business side, with the Columbia j-school's study on what we know so far about the viability of various digital journalism business models. As Poynter's Bill Mitchell suggested, the best entry point into the 146-page report might be the nine recommendations that form its conclusion. Buy Diflucan no prescription, Mitchell summed the report up in three themes: The audience for journalism is growing, though translating that into revenue is a challenge; the old model of banner ads isn't cutting it, and news orgs need to look for new forms of advertising; and news orgs need to play better with aggregators and sharpen their own aggregation skills. In his response to the study, Reuters' Felix Salmon focused on the advertising angle, arguing that journalism and advertising have too long been linked by mere adjacency and that "when you move away from the ad-adjacency model, Diflucan dangers, however, things get a lot more interesting and exciting."

The New York Times' story on the report centered on advertising, too, particularly the growing need for journalists to learn about the business side of their products. (That was media consultant Mark Potts' main takeaway, too.) Emily Bell, a scholar at the center that released the study, said that while journalists need to understand the business of their industry, integrating news and sales staffs isn't necessarily the way to go, Diflucan Cost. Australia, uk, us, usa, The J-Lab's Jan Schaffer recommended that news orgs respond to their business problems by learning from smaller startups and incorporating them more thoroughly into the journalism ecosystem. And paidContent's Staci Kramer advised news orgs to focus on regular audiences rather than fly-by visitors: "Outwardly we like to complain about content farms; in reality, a lot of what news outlets are doing to the side of those front-page stories isn’t very different."

—

Facebook's growth as news driver: The other major report was released by the Pew Research Center's Project for Excellence in Journalism and looked at how people access news on the web. This study, too, found that despite a small core of frequent users, online Diflucan without a prescription, news sites are dependent on casual users who visit sites infrequently and don't stay long when they're there. Poynter's Rick Edmonds conveniently distilled the study into five big takeaways. Diflucan Cost, The study also found that while Google is still the top referrer to major news sites, Facebook is quickly emerging as a significant news driver, too. University of British Columbia j-prof Alfred Hermida said this lines up with recent research he's done among Canadians, and GigaOM's Mathew Ingram said it showed that while Google is a dominant source for online news now, Diflucan natural, Facebook is primed to succeed it.

Meanwhile, the study also found that surprisingly little traffic to news sites is driven by Twitter. Lauren Dugan of All Twitter said this finding casts some doubt on the idea that Twitter is "a huge link-sharing playground," though the Wall Street Journal's Zach Seward said the study misses that Twitter referrals are undercounted.

The Twitter undercounting was one of several problems that TBD's Steve Buttry had about the study, where can i buy cheapest Diflucan online, including inconsistent language to characterize findings and a bias toward large news organizations. "This study probably has some helpful data, Diflucan Cost. But it has too many huge holes and indications of bias to have much value," Buttry wrote.

—

Pricing ads and subscriptions on tablets: Condé Nast became the third major magazine publisher to reach an agreement with Apple on app subscriptions, Online buying Diflucan, and one of the first to offer an in-app subscription, with The New Yorker available now. (Wired subscriptions are coming next month.) Time Inc., which reached a deal with Apple last week, clarified that it won't include in-app subscriptions, which would be where Apple takes that now-infamous 30% cut, Diflucan from canada. The Financial Times, meanwhile, is still negotiating with Apple.

Forbes' Jeff Bercovici explained why publishers may be warming to Apple's deal Diflucan Cost, : Turns out, more people are willing to share their personal data with publishers feared. Still, Diflucan online cod, Mathew Ingram of GigaOM used iFlowReader's bad Apple experience as a warning to other companies about the dangers of getting into bed with Apple.

Now that Apple-publisher relations have thawed, the New York Times' David Carr moved to the next issue: Negotiations between publishers and advertisers over how valuable in-app ads are, and how much those ads should cost. Time.com's Chris Gayomali wondered why magazines are more than giving away app subscriptions with print subscriptions, and concluded that it's about getting more eyeballs on the print product, Diflucan overnight, not the app, in order to maintain the all-important ad rate base.

In other words, Carr said in another post, Is Diflucan addictive, publishers are following the old magazine model, where the product is priced below cost and the money is made off advertising instead. He questioned the wisdom of applying that strategy to tablets: "the rich advertising opportunity that will produce may be a less durable and less stable business than grinding out highly profitable circulation over the long haul."

—

A postmortem on Bin Laden coverage: It's now been close to two weeks since the news of Osama bin Laden's death broke on Twitter, but plenty of folks were still discussing how the story was broken and covered, Diflucan Cost. Gilad Lotan and Devin Gaffney of SocialFlow put together some fascinating visualizations of how the news spread on Twitter, especially the central roles of Donald Rumsfeld staffer Keith Urbahn and New York Times reporter Brian Stelter. Mashable's Chris Taylor concluded from the data that trustworthiness and having active followers (as opposed to just lots of followers) are more important than ever on Twitter.

Media consultant Frederic Filloux was mostly reassured by the way the traditional news outlets handled the story online: "For once, order Diflucan from United States pharmacy, editorial seems to evolve at a faster pace than the business side." There were still folks cautioning against going overboard on Twitter-as-news hype, while the Telegraph's Emma Barnett wondered why pundits are still so surprised at the significant role Twitter and Facebook play in breaking news. ("It's exactly what they were designed for.")

New York Times public editor Arthur Brisbane gave the blow-by-blow of how his paper responded to the story, highlighting a few tweets by Times reporters and editors. Reuters' Felix Salmon chastised Brisbane Diflucan Cost, for not including Brian Stelter's tweets, which were posted a good 15 minutes before the ones he included. Herbal Diflucan, The exclusion, Salmon surmised, might indicate that the Times doesn't see what Stelter did on Twitter as reporting.

Google News founder Krishna Bharat compared the way Google handled 9/11 and Bin Laden's death, marveling at how much more breaking-news coverage is available on the web now. The Lab's Megan Garber used the occasion to glean some insights from Bharat about trusting the authority of the algorithm to provide a rich palette of news, order Diflucan online overnight delivery no prescription, but at Search Engine Land, Danny Sullivan used the Bin Laden coverage to point out some flaws in Google News' algorithm.

—

Reading roundup: Lots of interesting little rabbit trails to choose from this week. Here are a few:

— ComScore's April traffic numbers are out, and there were a number of storylines flowing out of them: Cable news sources are beating print ones in web traffic, the New York Times' numbers are down (as expected) after implementation of its paywall, and Gawker's numbers are starting to come back after dropping last year with its redesign, Diflucan Cost.

— Last week, Diflucan no rx, ESPN columnist Rick Reilly told graduating students at the University of Colorado's j-school to never write for free. That prompted Jason Fry of the National Sports Journalism Center and Craig Calcaterra of MSNBC.com's Hardball Talk to expound on the virtues of writing for free, though Slate's Tom Scocca took Reilly's side.

— Two thoughtful pieces on brands and journalism: Jason Fry at Poynter on assessing the value of organizational and personal brands, and Vadim Lavrusik at the Lab on journalists building their brands via Facebook.

— Late last week, Google lost an appeal to a 2007 Belgian ruling forcing it to pay newspapers for gaining revenue for linking to their stories on Google News.

— Finally, the Huffington Post's Mandy Jenkins offered a helpful list of 10 ways journalists can use Storify. It's full of great examples and should spark an idea or two.

June 1st, 2011

Armour Dosage

[This review was originally posted at the Nieman Journalism Lab Armour Dosage, on May 6, 2011.]

Twitter as breaking-news system: This week's big news is obvious: American forces killed Osama bin Laden on Monday (Sunday for most Westerners) in a raid of his compound in Abbottabad, Pakistan. But you already knew that, and how exactly you found out is the first angle I want to look at. The news blew up on Twitter and Facebook late Sunday night after the White House announced President Obama would be addressing the nation. The ensuing frenzy set a record for the highest volume of sustained activity on Twitter, with an average of 3, Armour results, 000 tweets per second for about three hours. While most Americans first got the news from TV, about a fifth of young people found out online.

That led to another round of celebration of Twitter as the emerging source for big breaking news — Business Insider's Matt Rosoff called the story Twitter's CNN moment and said Twitter was "faster, more accurate, and more entertaining than any other news source out there." PR guru Brian Solis described Twitter as "a perfect beast for committing acts of journalism," and University of British Columbia j-prof Alfred Hermida said it's becoming routine to see Twitter as the first option for breaking news coverage, Armour Dosage.

Others pushed back against that praise: Advertising Age's Simon Dumenco argued that everyone on Twitter was still waiting for confirmation from government officials and the mainstream media, and Dan Mitchell of SF Weekly said that most of the people tweeting the news were from traditional media anyway. The American Journalism Review's Rem Rieder said the aide who broke the story on Twitter wasn't doing journalism, but just passing on a rumor, Armour description. And Engadget vet Joshua Topolsky said the Twitter buzz probably says more about our need to tell others we got to the news first than it does about Twitter.

Several folks staked out a spot between the two positions. TechCrunch's Erick Schonfeld Armour Dosage, said Twitter doesn't supplant traditional media, but it does amplify it and drive people to it. GigaOM's Mathew Ingram advised us to think about it not in terms of competition between old and new media, but as part of a news ecosystem: "it’s not really about Twitter or Facebook; it’s about the power of the network." Elsewhere, media analyst Dan Gillmor compared this story to how the 9/11 news broke, Armour gel, ointment, cream, pill, spray, continuous-release, extended-release, GigaOM's Stacey Higginbotham classified the seven stages of breaking news on Twitter, and Search Engine Land's Danny Sullivan looked at the way Google responded to the story.

Three other mini-stories within the digital aspect of the Bin Laden story: First, regarding traditional media outlets' online efforts, former Guardian digital chief Emily Bell wrote a fantastic piece about how live news coverage is the great challenge of our time for news orgs, the Online Journalism Review's Robert Niles critiqued the performance of mobile news sites, and the BBC's Rory Cellan-Jones ripped some news iPad apps for being slow with the story, ordering Armour online.

Second, there was plenty of discussion about the remarkable story of Pakistani programmer Sohaib Athar, who live-tweeted the raid without knowing it. Poynter's Steve Myers went meta with the account of how we found out about him, revealing some interesting examples of how information travels through a network like Twitter. He then defended Athar as a citizen journalist, Armour Dosage. Armour dosage, And third, the Atlantic's Megan McArdle explained how a quotation got misattributed to Martin Luther King Jr. and then went viral, and Frederic Lardinois of NewsGrange mused about the difficulty of social media corrections.

—

Osama and the Times' pay wall: While we've been focusing on the digital media side of things so far, Bin Laden's death was the type of massive story that traditional news organizations go into overdrive on, too, buy no prescription Armour online. Poynter and the Columbia Journalism Review have great looks at how news orgs played the story in print and online, and we got some behind-the-scenes glimpses at how the New York Times, Chicago Tribune, What is Armour, CNN, and other mainstream journalists put together reports on such quick deadlines. Armour Dosage, The Times made an interesting decision in the wake of the story not to lift its pay wall/gate/fence for news on Bin Laden's death, even though it had previously expressed a willingness to allow free access for big stories. The Lab's Megan Garber asked a number of questions about that issue — who makes that decision. And if this isn't a huge story, what is? — and noted that the fact that it was the beginning of the month and many users' meters had just been reset played into the decision.

Meanwhile, James Rainey of the Los Angeles Times criticized the cheerleading tone of TV news' coverage, and Slate's Jack Shafer called out some of the inaccuracies in news stories on Bin Laden's death.

—

Giving reporters social-media leeway: We saw a case study in contrasting newsroom social media policies, starting when Bloomberg' guidelines were leaked to eMedia Vitals last week. It encouraged reporters to use Twitter, with several restrictions listed under one strong caveat: "Ask questions first, Armour Dosage. Armour maximum dosage, Tweet later."

A couple of days later, John Paton of the Journal Register Co. posted his own company's social media policy. It was blank — implying that the company doesn't put any explicit restrictions on what or how employees can post. Techdirt's Mike Masnick praised Paton's philosophy: "These things are developing quickly, and for people to find out how to use these tools most efficiently and effectively, they need to feel free to experiment and do whatever needs to be done."

That prompted GigaOM's Mathew Ingram to give his own social media advice for journalists, buy cheap Armour no rx, telling them to talk to people, link, retweet, reply when spoken to, admit when they're wrong and be human — but not too human. Armour Dosage, Michele McLellan of the Knight Digital Media Center, meanwhile, defined online engagement in terms of outreach, conversation, and collaboration. Armour trusted pharmacy reviews, —

Publishers begin to jump in with Apple: A couple of big media-on-iPad developments this week: Time Inc. reached a deal with Apple to allow magazine subscribers to get iPad apps for free, and Hearst became one of the first major publishers to agree to offer subscriptions within iPad (which means Apple's getting that 30% cut), though Advertising Age's Nat Ives wondered if Condé Nast will beat Hearst to the punch.

The British newspaper the Telegraph also launched an iPad edition, and the Guardian's Stuart Dredge noted that both the Telegraph and Hearst are asking customers to share their personal data with them (Apple already gets customer data), and the Telegraph is giving an incentive to them to do so. Meanwhile, Armour without a prescription, the company Yudu has launched some sort of service that will somehow allow publishers to evade Apple's 30% in-app subscription cut and apparently got Apple's approval. (As you can tell, details are sketchy at this point.)

Elsewhere in news on the iPad, News Corp. said it's lost $10 million on The Daily this quarter, which has reportedly gotten 800,000 downloads, Armour Dosage. Former Marketwatch CEO Larry Kramer said The Daily is gradually getting better, Purchase Armour, though.

—

Pardon AOL's dust: Arianna Huffington keeps on cleaning house at AOL, with a handful of new changes each week. This week: AOL News was folded into the Huffington Post, and Patch announced they're launching Patch Latino sites in California and unveiled the hyperlocal blogging network for which it's been recruiting volunteers for the past couple of weeks. Forbes' Jeff Bercovici reported that AOL is continuing to pour millions of dollars into Patch and expects to lose money on the site this year. Armour Dosage, Even if Patch works journalistically, Mathew Ingram said, that doesn't mean it'll make any business sense.

The Next Web's Alex Wilhelm warned of the homogenization threatened by the AOL content empire and NPR's On the Media debated whether the Huffington Post is good for journalism, japan, craiglist, ebay, overseas, paypal. Amid the hand-wringing, Lauren Rabaino of 10,000 pointed out five good things Patch sites are doing, including transparency and accountability by editors.

—

Reading roundup: Believe it or not, Armour pictures, people in media circles talked about things this week that didn't have to do with Osama bin Laden or AOL. Here are a few of them:

— Marco Arment's post last week about his successful experiments in charging for Instapaper turned into an interesting discussion about creating a freemium or "business class" for news. Here's Frederic Filloux, Oliver Reichenstein, and Mathew Ingram, Armour Dosage.

— Another noteworthy conversation that sprung week: Scott Rosenberg, Dave Winer, and Amy Gahran on why journalists should be wary of Facebook — because eventually, as Rosenberg said, "it’s not the public sphere, not in the way the Internet itself is. It’s just a company."

— The Wall Street Journal became the latest news org to launch a platform modeled after the WikiLeaks anonymous leaking concept, with SafeHouse. The Atlantic has plenty of details.

— Finally, two useful sets of tips: One from Poynter's Julie Moos about news blogging from filling in for Jim Romenesko for a week, and the other from TBD's Steve Buttry on possible revenue streams for newspapers.

May 5th, 2011

Bactrim Price

[This review was originally posted at the Nieman Journalism Lab Bactrim Price, on April 29, 2011.]

Leaking gets competitive: WikiLeaks made its first major document release in five months — during which time its founder, Julian Assange, was arrested, released on bail, and put under house arrest — this week, publishing 764 files regarding the Guantánamo Bay prison along with 10 media partners. (As always, The Nation's Greg Mitchell's WikiLeaks über-blogging is the place to go for every detail you could possibly need to know.)

That's more media partners than WikiLeaks has worked with previously, and it includes several first-timers, such as the Washington Post and McClatchy. As the Columbia Journalism Review's Joel Meares noted, Where can i buy Bactrim online, the list of partners doesn't include the New York Times and the Guardian, the two English-language newspapers who worked with WikiLeaks in its first media collaboration last summer. Despite being shut out, those two organizations were still able to force WikiLeaks' hand in publishing the leak, as the Huffington Post's Michael Calderone explained.

The Times got their hands on the documents independently, then passed them on to the Guardian and NPR, order Bactrim no prescription. This meant that, unlike the news orgs that got the info from WikiLeaks, they were operating without an embargo, Bactrim Price. As they prepared to publish last Sunday, WikiLeaks lifted its embargo early for its own partners (though the first to publish was actually the Telegraph, a WikiLeaks partner).

The New York Times' Brian Stelter and Noam Cohen said the episode was evidence that WikiLeaks "has become such a large player in journalism that some of its secrets are no longer its own to control." But, as they reported, Bactrim photos, WikiLeaks itself didn't seem particularly perturbed about it.

—

Patch's reaches for more bloggers: AOL seems to be undergoing a different overhaul every week since it bought the Huffington Post earlier this year, and this week the changes are at its hyperlocal initiative Patch, which is hoping to add 8,000 community bloggers to its sites over the next week or two in what its editor-in-chief called a "full-on course correction."

While talking to paidContent, AOL's folks played down the degree of change it's implementing, explaining that these new bloggers (who will be recruited from, Bactrim recreational, among other sources, the sites' frequent commenters) aren't disrupting the basic Patch model of one full-time editor per site. In fact, they'll be unpaid, something that's been a bit of a headache for AOL and HuffPo lately.

Business Insider's Nicholas Carlson liked the plan Bactrim Price, , saying volunteer bloggers can become "extremely effective word-of-mouth marketers" and "excellent pageview machines" with, of course, "manageable" salaries. Bactrim class, Others from MediaBistro and Wired were a little more skeptical of the no-pay factor. Lehigh j-prof Jeremy Littau took issue with a more systemic aspect of the new blogs, which will exist both on the writer's own site and on Patch. Splitting up the conversation with that arrangement won't be helpful for the individual blogs or for the local blogosphere as a whole, he said: "I see something developing that leads to less population in the local blogosphere and a walled-off system that operates on Patch. At worst, it will lead to parallel and fracture conversations online, which is death when we’re talking about hyperlocal."

—

Two new media manifestos: Two New York j-profs — and two of the more prominent future-of-news pundits online these days — both published manifestos of sorts this week, effects of Bactrim, and both are worth a read. Jay Rosen summed up what he's learned about journalism in 25 years of teaching and thinking about it at NYU, and CUNY's Jeff Jarvis gave a few dozen bullet points outlining his philosophy of news economics.

Rosen's post touched on several of the themes that have colored his blog and Twitter feed over the past few years, including the value of increasing participation, the failure of "objectivity," and the need for usefulness and context in news, Bactrim Price. But the ideas weren't exactly new, the conversation they generated was stimulating. Bactrim interactions, The comments chase down some interesting tangents, and GigaOM's Mathew Ingram expanded on Rosen's point about participation, arguing that even if the number of users who want to participate is relatively low, opening up the process can still be immensely important in improving journalism. Rosen also inspired TBD's Steve Buttry to write his own "what I know about news" post.

Like Rosen's post, Jarvis' wouldn't break a whole lot of ground for those already familiar with his ideas, my Bactrim experience, but it summed them up in a helpfully pithy format. Bactrim Price, He focused heavily on providing real value ("The only thing that matters to the market is value"), the importance of engagement, and finding efficiencies in infrastructure and collaboration. His post contains plenty of pessimism about the current newspaper business model, and Mathew Ingram and FishbowlNY's Chris O'Shea defended him against the idea that he's just a doomsayer.

—

Times paywall bits: The New York Times spent a reported $25 million to develop its paid-content system, and it will be spending another $13 million on the plan this year, Bactrim without prescription, mostly for promotion. Women's Wear Daily detailed those promotional efforts, which include posters around New York as well as TV spots. PaidContent's Robert Andrews compared the Times' pay plan to that of theother Times (the one in London, owned by Rupert Murdoch), noting that the New York Times' plan should allow them to draw more revenue while maintaining their significant online influence, something the Times of London hasn't done at all (though it's largely by choice), Bactrim from canadian pharmacy.

Meanwhile, Terry Heaton found another (perhaps more convoluted) way around the Times' system, tweeting links to Times stories that he can't access, Bactrim Price. And elsewhere at the Times, the Lab's Megan Garber explored the Times' R&D Lab's efforts to map the way Times stories are shared online.

And elsewhere in paywalls, the CEO of the McClatchy newspaper chain has reversed his anti-paywall stance and said this week the company is planning paywalls for some of its larger papers, and Business Insider introduced us to another online paid-content company, Buy Bactrim online no prescription, Tiny Pass.

—

Apps, news, and pay: In his outgoing post on Poynter's Mobile Media blog, Damon Kiesow had a familiar critique for news organizations' forays into mobile media — they're too much like their print counterparts to be truly called innovative. But he did add a reason for optimism, pointing to the New York Times' News.me and the Washington Post's Trove: "Neither is a finished product or a perfect one, get Bactrim. But both were created by newspaper companies that put resources into research and development."

Media analyst Ken Doctor said Bactrim Price, local news needs to start moving toward mobile media to reach full effectiveness, laying out the model of an aggregated local news app pulling various types of media. For maximum engagement, that app had better include audio, according to some NPR statistics reported by the Lab's Andrew Phelps.

There may a bigger place for paid apps than we've thought: Instapaper's Marco Arment twice pulled the free version of the app for about a month and found that sales actually increased. He made the case against free apps, Kjøpe Bactrim på nett, köpa Bactrim online, saying they bring low conversion rates, little revenue, and unnecessary image problems. Meanwhile, makers of one free app, Zite, said they're releasing a new version to deal with complaints they've been getting from publishers about copyright issues, about Bactrim.

—

Reading roundup: No big stories this week, but tons of little things to keep up on, Bactrim Price. Here's a bit of the basics:

— On social media: Facebook launched a "Send" plugin among a few dozen websites (including a couple of news sites) that allows private content-sharing. The Next Web's Lauren Fisher argued that journalists should spend more time using Facebook, and Canadian j-prof Alfred Hermida wrote about a study he helped conduct about social media and news consumption.

— The Guardian shut down a local-news project it launched last year, saying the local blogs were "not sustainable." PaidContent's Robert Andrews said that while the blogs were useful, Bactrim cost, there are few examples of sustainable local-news efforts, and Rachel McAthy of Journalism.co.uk rounded up some opinions to try to find the value in the Guardian's experiment.

— The news filtering program launched in public beta this week, prompting a New York Times profile and pieces by GigaOM's Mathew Ingram and the Knight Digital Media Center's Amy Gahran on the journalistic value of curation.

— Thanks to its most recent content-farm-oriented algorithm tweak, Google's traffic to all Demand Media sites is down 40%, which caused Demand stock to slide this week. Google, meanwhile, added some more automatic personalization features to Google News.

— The Lab's Andrew Phelps wrote a great piece expounding on the journalistic utility of the humble (well, kind of humble) smartphone.

— And for your deep-thinking weekend-reading piece, Harvard researcher Ethan Zuckerman's thoughtful take on overcoming polarization by understanding each other's values, rather than just facts.

May 5th, 2011

Synthroid No Rx

[This review was originally posted at the Nieman Journalism Lab Synthroid No Rx, on April 22, 2011.]

Is Flipboard a competitor or collaborator?: Flipboard has quickly become one of the hottest news apps for the iPad, and it continued its streak last week when it announced it had raised $50 million in funding. Flipboard's Mike McCue told All Things Digital's Kara Swisher he'd be using the money to hire more staff and expand onto other devices, including the iPhone and Android platform. But he also talked to TechCrunch about using the money to fend off a rumored competitor in development at Google. (The Houston Chronicle's Dwight Silverman told Google not to bother, because Zite already does the trick for him.)

All this prompted a fantastic analysis of Flipboard from French media consultant Frederic Filloux, buying Synthroid online over the counter, who explained why Flipboard's distinctive user-directed blend of news media sites, RSS feeds, and social media is so wonderful for users but so threatening to publishers. Filloux argued that every media company should be afraid of Flipboard because they've built a superior news-consumption product for users, Where to buy Synthroid, and they're doing it on the backs of publishers. But none of those publishers can complain about Flipboard, because any of them could have (and should have) invented it themselves.

GigaOM's Mathew Ingram advised media companies to be willing to work with Flipboard for a similar "if you can't beat 'em, join 'em" reason: Its app has their apps beat in terms of customizability and usability, so they're better off trying to make money off of it than their own internal options, Synthroid No Rx. ReadWriteWeb's Dan Rowinski wrote about the possibility that Flipboard could be a better alternative partner for publishers than Apple, and Marshall Kirkpatrick wondered why publishers are up in arms about Flipboard in the first place.

—

Traditional media's personalized news move: One of the reasons that media companies might be less than willing to work with Flipboard is that some of them are building their own personalized news aggregation apps, two of which launched this week: The Washington Post Co.'s Trove and Betaworks' News.me, developed with the New York Times, buy Synthroid without prescription. INFOdocket's Gary Price has the best breakdown of what Trove does: It uses your Facebook account and in-app reading habits to give you personalized "channels" of news, determined by an algorithm and editors' picks — a bit of the "Pandora for news" idea, as the Post's Don Graham called it. (It's free, Synthroid steet value, so it's got that going for it, which is nice.)

All Things Digital's Peter Kafka suspected that Trove will be most useful on mobile media, as its web interface won't be much different from many people's current personalized home pages, and David Zax of Fast Company emphasized the social aspect of the service.

News.me is different from Trove in a number of ways Synthroid No Rx, : It costs 99 cents a week, and it's based not on your reading history, but on what other people on Twitter are reading. (Not just what they're tweeting, but what they're reading — Betaworks' John Borthwick called it reading "over other people's shoulders.") It also pays publishers based on the number of people who read their content through the app, Synthroid duration. That's part of the reason it's gotten the blessing of some media organizations that aren't typically aggregator friendly, like the Associated Press.

Since News.me is based so heavily on Twitter, it raises the obvious question of whether you'd be better off just getting your news for free from Twitter itself. Synthroid mg, That's what Business Insider's Ellis Hamburger wondered, and Gizmodo's Adrian Covert answered a definitive 'no,' though Martin Bryant of The Next Web said it could be helpful in stripping out the chatter of Twitter and adding an algorithmic aspect. GigaOM's Mathew Ingram looked at both services and concluded that they signal a willingness by some traditional media outlets to adjust their longtime broadcasting role to the modern model of the "Daily Me."

—

A good sign for the Times' pay plan: The overall news from the New York Times Co.'s quarterly earnings report this week wasn't good — net income is down 57% from a year ago — but there was one silver lining for online paid-content advocates: More than 100,000 people have begun paying for the Times' website since it began charging for access last month, Synthroid No Rx. (That number doesn't include those who got free subscriptions via Lincoln, but it does include those who are paying though cheaper introductory trials.)

As Advertising Age's Nat Ives pointed out, there's a lot that number doesn't tell us about traffic and revenue (particularly, where can i cheapest Synthroid online, as paidContent's Staci Kramer noted, how many people are paying full price for their subscriptions), but several folks, including Glynnis MacNicol of Business Insider, Low dose Synthroid, were surprised at how well the Times' pay plan is doing. (Its goal for the first year was 300,000 subscribers.) She said the figure compares favorably with the Financial Times, which got its 200,000th subscriber this year, nine years into its paywall, Synthroid canada, mexico, india.

Those numbers are particularly critical for the Times given the difficulty its company has had over the past several years — as Katie Feola of Adweek wrote, many analysts believe the pay plan is crucial for the Times' financial viability. "But this means the paper's future rests on an untested model that many experts believe can't work in the oversaturated news market," she wrote. "And the Times has to pray the ad market won’t decline faster than analysts predict."

A few other paid-content tidbits: Nine of Slovakia's largest news organizations put up a paywall together this week, and the pope is apparently pro-paywall, Synthroid use, too. At the Guardian, Cory Doctorow mused about how companies can (and can't) get people to pay for the content online in an age of piracy.

—

Google's hammer falls on eHow: When Google applied its algorithm adjustment last month Synthroid No Rx, to crack down on content farms, Demand Media's eHow actually came out better off (though others didn't fare so well, like the New York Times Co.'s About.com, as we found out this week). Google made a second round of updates last week, and eHow got nailed this time, losing 66% of their Googlejuice, Synthroid from mexico, according to Sistrix.

Search Engine Land's Matt McGee speculated that Google might have actually been surprised when eHow benefited the first time, and may have made this tweak in part as an effort to "correct" that. Demand Media, Synthroid treatment, meanwhile, called Sistrix's eHow numbers"significantly overstated," though the company's stock hit a new low on Monday. Mathew Ingram said investors have reason to worry, as Demand's success seems to be at the mercy of Google's every algorithm tweak.

—

A Pulitzer first: The Pulitzer Prizes were announced this week, and while the awards were spread pretty broadly among several news organizations, there were a couple of themes to note, Synthroid No Rx. As Felix Salmon and others pointed out, buy generic Synthroid, an abnormally large share of the awards went to business journalism, a trend the Columbia Journalism Review's Dean Starkman opined on in a bit more detail.

The biggest prize from a future-of-news perspective may have gone to ProPublica, whose series on some of the machinations that worsened the financial crisis was the first Pulitzer winner to never appear in print. Purchase Synthroid online, The Lab's Justin Ellis noted that other winners are including significant multimedia components, perhaps signaling a shift in the emphasis of one of journalism's most elite institutions. If you were wondering where WikiLeaks was in all this, well, the New York Times didn't submit its WikiLeaks-based coverage.

—

Reading roundup Synthroid No Rx, : No huge stories this week, but a few little things that are worth noting:

— Your weekly AOL/Huffington Post update: Jonathan Tasini came out swinging again regarding his lawsuit on behalf of unpaid HuffPo bloggers, Business Insider's Glynnis MacNicol responded in kind, Eric Snider told the story of getting axed from AOL's now-defunct Cinematical blog, and HuffPo unveiled features allowing readers to follow topics and writers.

— Missouri j-school students are chafing against requirements that they buy an iPad (they previously had to buy iPod Touches, canada, mexico, india, and they called that plan a bust). Meanwhile, Ben LaMothe of 10,000 Words had three ideas of social media skills that j-schools should teach.

— A weird little fake-URL spoof turned into an interesting discussion about the possibility of libel through fake URLs, in thoughtful posts by both the Lab's Andrew Phelps and TechCrunch's Paul Carr.

— Two interesting data points on news innovation: A group led by Daniel Bachhuber put together some fascinating figures about and perspectives from Knight News Challenge grant recipients. And journalism researchers Seth Lewis and Tanja Aitamurto wrote at the Lab about news organizations using open API as a sort of external R&D department.

May 5th, 2011

Flagyl Cost

[This review was originally posted at the Nieman Journalism Lab Flagyl Cost, on April 15, 2011.]

Are HuffPo bloggers being exploited?: Arianna Huffington spent last week axing many of AOL's paid writers, and this week she heard from a few of the unpaid ones in the form of a class-action lawsuit filed by Huffington Post bloggers, led by longtime HuffPo blogger Jonathan Tasini. The Washington Post explained Tasini's claims that HuffPo had breached its contract with bloggers by failing to come through the "implied promise" of compensation, and that it was "unjustly enriched" by the unpaid bloggers' contributions. PaidContent, Buy Flagyl without a prescription, meanwhile, said this suit isn't much like Tasini's suit against The New York Times.

Reaction to the suit online was virtually universal: Most everyone agreed that this suit is a non-starter. Huffington herself did the best job of bringing together the various suit slams, arguing, like many of them, buy Flagyl from mexico, that the exposure that HuffPo provides is plenty of compensation for its bloggers: "People blog on HuffPost for free for the same reason they go on cable TV shows every night for free: either because they are passionate about their ideas or because they have something to promote and want exposure to large and multiple audiences."

Many of the critiques of the suit make similar points, so I'll just hit the highlights. Mike Masnick of TechDirt put the sharpest point on it: "You, Flagyl forum, of your own free will, agree to contribute work for free. Then, you file a lawsuit complaining that this is depressing the market for your work, Flagyl Cost. And you expect anyone to take you seriously?" Business Insider's Glynnis MacNicol and Slate's Jack Shafer also made the argument well, with MacNicol speaking from experience as a HuffPo blogger and Shafer noting that Tasini was happy with his arrangement until he saw some money could be had.

Others extended Tasini's logic to more absurd conclusions: Conservative legal blogger Eugene Volokh said if Tasini were right, order Flagyl online c.o.d, he'd be exploiting his commenters, and CUNY j-prof Jeff Jarvis extended the same analogy to Wikipedians and Little League coaches. PR professional Simon Owens saw a dangerous precedent for other sites with free contributors. Discount Flagyl, John Bethune of B2B Memes wrote, tongue-in-cheek, that perhaps Huffington owes all of us some money for making her site valuable by reading it over the years.

Still Huffington's way obviously isn't the only one: Forbes' Jeff Bercovici talked to the New York Times Flagyl Cost, about why they pay their (non-public figure) op-ed contributors. And a few other notes about Huffington's ongoing AOL revamp — Advertising Age's Michael Learmonth on AOL's new aggregation-heavy strategy, Patch is hiring as the new model is extended to its sites, order Flagyl from mexican pharmacy, and Bercovici's account of the grievances of the newly laid-off "freelancers."

—

Some unclear data on the Times' pay plan: It's only been a couple of weeks since the New York Times put up its metered pay system, but we got our first glimpse at its effect on the Times' traffic this week with some numbers from Heather Dougherty at Hitwise. Compared with the 12 days before the system went into place, Doses Flagyl work, the Times' unique visitors down between 5% and 15% per day and its page views down 11% to 30%. PaidContent's Joseph Tarkatoff has a few good bits of analysis of the figures.

Those numbers fell in that ambiguous no man's land between success and failure, allowing both supporters and skeptics of the plan to claim them as confirmation. Nate Silver of the Times' FiveThirtyEight called the data "very promising" if it holds, and Business Insider's Noah Davis noted that the Times' dropoff was smaller than Gawker's post-redesign decline, cheap Flagyl. On the other side, Mathew Ingram of GigaOM said that 15% is a high number of its readers for the Times to lose, suggesting that even the threat of a paywall has been enough to deter them from visiting, Flagyl Cost. Likewise, Mike Masnick of Techdirt called it "an awful lot of potential ad revenue lost."

Others were less willing to make pronouncements: VentureBeat's Anthony Ha called the change "only natural" but said it could be dangerous if it continues. Both he and Chris O'Shea of FishbowlNY said it's too early to determine anything meaningful yet, Buy Flagyl online no prescription, though. Media analyst Ken Doctor, meanwhile, took a closer look at the Times' subscription sponsorship deal with the carmaker Lincoln.

Elsewhere in the world of online news paywalls, Flagyl class, paidContent's Robert Andrews reported on the UK government's ongoing efforts to make walled-off material available for free through libraries, and Mashable's Meghan Peters explored the ways paywalls are affecting news orgs' social media strategies.

—

Identifying devoted fans through Facebook: Facebook launched Flagyl Cost, a new "Journalists on Facebook" page last week as part of an effort to draw attention to its possible uses for news organizations, and Josh Constine of Inside Facebook argued this week that while the journalism world seems to be particularly enamored with Twitter right now, Facebook's richer content options could pay off more in the long run, though they might require more effort than Twitter does.

The New Yorker tried out one of those Facebook-centric strategies in a novel way this week by making a Jonathan Franzen story available online only to people who "liked" Conde Nast on Facebook. Flagyl dose, The magazine's spokeswoman, Alexa Cassanos, told Poynter's Damon Kiesow the "like-wall" was not an effort to boost its Facebook fan count, but to find people who are fans of long-form journalism on a deeper level. Rather than a pile of casually interested fans, about Flagyl, Cassanos said, "We would much rather have a few thousand fans who really enjoy the content and stick with it."

On the Twitter side of things, former CEO Evan Williams wrote a thoughtful post trying to untangle the thicket of online identity by organizing it into a framework of categories he developed with Twitter CTO Greg Pass: Authentication, Flagyl pharmacy, representation, communication, personalization, and reputation. (I should note that while the framework was developed at Twitter, order Flagyl online overnight delivery no prescription, it was thought up with the whole web in mind.) Tech conference organizer Eric Norlin tweaked Williams' categories and suggested breaking it down by the specificity with which things are associated with us.

Web thinker Stowe Boyd, meanwhile, critiqued it as being too tools- or marketing-centric while ignoring the more philosophical aspects of online identity, like publicy and context, Flagyl Cost. Mathew Ingram of GigaOM concurred with him, saying that a transactional idea of identity misses the larger, Buy cheap Flagyl no rx, messier aspects of how we define ourselves online, offering the failure of Google Buzz as an example.

—

Reading roundup: Lots of little bits and pieces this week to go with our continued fixation on AOL and the New York Times. Here's a quick tour:

— I'm a bit surprised it didn't generate more buzz, but WikiLeaks' Julian Assange made his first public appearance since his December arrest last weekend, defending WikiLeaks' accountability at a British debate, and taking questions via Skype at a UC-Berkeley conference.

— A couple of interesting items regarding linking: Reuters' Anthony DeRosa wondered why traditional media orgs don't link out more, and USC's Robert Niles talked to Maryland j-prof Ronald Yaros about a study he led that found that explanatory links work best in news stories — provided they're placed inside explanatory text.

— According to Poynter's Damon Kiesow, we got a surprising entry in the iPad news app field this week: Bing.

— Finally, two thoughtful pieces — one from British journalist Kevin Anderson on the need to rethink what exactly newspapers do, and an interview by the Lab's C.W. Anderson with the Reuters Institute's David Levy and Danish j-prof Rasmus Kleis Nielsen on the need to take the future-of-news conversation beyond the U.S.

Mark Coddington

Associate Professor, Washington and Lee University

this week

Diflucan Cost

Armour Dosage

Bactrim Price

Synthroid No Rx

Flagyl Cost